“Severe Hypoalbuminemia Increases the Risk of Thrombocytopenia in Critically Ill Adult Patients Receiving Teicoplanin” (2019) Dhaka University Journal of Pharmaceutical Sciences, 18(2), pp. 153–157. doi:10.3329/dujps.v18i2.43257.